Concepedia

Michal Stark

MS

25

Publications

1.2K

Citations

18

H-Index

2003

Active since

Affiliations

Technion – Israel Institute of Technology(Current)

Amsterdam UMC Location Vrije Universiteit Amsterdam

Vrije Universiteit Amsterdam

Michal Stark is an author at Technion – Israel Institute of Technology specializing in medicine, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

2003–2022

25

Publications

25

Arabinogalactan−Folic Acid−Drug Conjugate for Targeted Delivery and Target-Activated Release of Anticancer Drugs to Folate Receptor-Overexpressing Cells

Roy I. Pinhassi, Yehuda G. Assaraf, Shimon Farber et al. · Biomacromolecules · 2009 · 136 citations

Chemotherapeutic Drug-Induced ABCG2 Promoter Demethylation as a Novel Mechanism of Acquired Multidrug Resistance

Eran Bram, Michal Stark, Shachar Raz et al. · Neoplasia · 2009 · 116 citations · Full text

, , +22

Lysosomotropic drugs activate TFEB via lysosomal membrane fluidization and consequent inhibition of mTORC1 activity

Benny Zhitomirsky, Anna Yunaev, Roman Kreiserman et al. · Cell Death and Disease · 2018 · 107 citations · Full text

Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers

Yamit Adar, Michal Stark, Eran Bram et al. · Cell Death and Disease · 2012 · 98 citations · Full text

Aberrant splicing of folylpolyglutamate synthetase as a novel mechanism of antifolate resistance in leukemia

Michal Stark, Chen Wichman, Irit Avivi et al. · Blood · 2009 · 88 citations · Full text

Rows per page

1–5 of 25